Latest News

Cancer drugs block dementia-linked brain inflammation, study finds

A class of drugs developed to treat immune-related conditions and cancer -- including one currently in clinical trials for glioblastoma and other tumors -- eliminates neural inflammation associated with dementia-linked diseases and brain injuries, according to researchers. In their study, the researchers discovered that the drugs, which can be delivered orally, eradicated microglia, the primary immune cells of the brain. These cells exacerbate many neural diseases, including Alzheimer's and Parkinson's, as well as brain injury.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Gene variant linked to schizophrenia, bipolar disorder, alcoholism

  • Manipulating key protein in brain holds potential against obesity, diabetes

  • Anti-inflammatory drug can prevent neuron loss in Parkinson's model

  • Brain tumor causes, risk factors elude scientists

  • Why don't genetically identical cells behave identically? Cellular noise

  • Metastatic brain tumor treatment could be on the horizon with use of SapC-DOPS

  • Protein couple controls flow of information into brain's memory center

  • How stress hormones promote brain's building of negative memories

  • Increased levels of the body's own cannabinoids impair embryonic brain development

  • Rigid connections: Molecular basis of age-related memory loss explained

  •